SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027296
Filing Date
2018-05-11
Accepted
2018-05-11 08:21:15
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv493170_10q.htm 10-Q 376276
2 EXHIBIT 31.1 tv493170_ex31-1.htm EX-31.1 7729
3 EXHIBIT 31.2 tv493170_ex31-2.htm EX-31.2 7716
4 EXHIBIT 32.1 tv493170_ex32-1.htm EX-32.1 4116
5 EXHIBIT 32.2 tv493170_ex32-2.htm EX-32.2 4077
  Complete submission text file 0001144204-18-027296.txt   3833942

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20180331.xml EX-101.INS 857612
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20180331.xsd EX-101.SCH 33028
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20180331_cal.xml EX-101.CAL 29321
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20180331_def.xml EX-101.DEF 263484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20180331_lab.xml EX-101.LAB 284948
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20180331_pre.xml EX-101.PRE 295216
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 18824970
SIC: 2834 Pharmaceutical Preparations